99% Purity Nmn CAS 1094-61-7 β-Nicotinamide Mononucleotide Powder
Baooute is a very professional supplier of 99% Purity Nmn CAS 1094-61-7
β-Nicotinamide Mononucleotide Powder, people usually buy NMN Powder with competitive price from Baooute.
| Product Name |
NMN / Nicotinamide mononucleotide |
| Appearance |
White powder |
| Purity |
99% |
| Molecular Weight |
Weight: 334.22 |
| CAS No |
1094-61-7 |
| Molecular Formula |
C11H15N2O8P |
Nicotinamide mononucleotides play an important role in the production of human cell energy, which is involved in the synthesis of intracellular NAD (nicotinamide adenine dinucleotide, an important coenzyme for cell energy conversion).
Diabetes is a chronic and progressive disease with continuously increasing prevalence, rising financial pressure on the worldwide healthcare systems. Recently, the insulin resistance, hallmark of type 2 diabetes, was cured in mice treated with NAD+ precursor
β-Nicotinamide Mononucleotide, no toxic effects being reported. The β-Nicotinamide Mononucleotide is an intermediate in NAD+ biosynthesis produced from nicotinamide (NAM) and phosphoribosyl pyrophosphate (PRPP) by nicotinamide phosphoribosyl transferase enzyme (Nampt).
β-Nicotinamide Mononucleotide is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide. In a Nampt+/- mouse model of metabolic disease, β-NMN (50-100 µM) has been used to enhance NAD biosynthesis and glucose-stimulated insulin secretion, demonstrating a role for Nampt in β cell function. Furthermore, at 500 mg/kg/day, β-NMN has been shown to ameliorate glucose intolerance in high-fat diet-induced type 2 diabetes mice by restoring NAD+ levels.
β-Nicotinamide Mononucleotide is a product of the nicotinamide phosphoribosyltransferase (NAMPT) reaction and a key NAD+ intermediate. The pharmacological activities of β-nicotinamide mononucleotide include its role in cellular biochemical functions, cardioprotection, diabetes, Alzheimer's disease, and complications associated with obesity.
β-Nicotinamide Mononucleotide has several beneficial pharmacological activities. Mostly mediated by its involvement in NAD+ biosynthesis, the pharmacological activities of NMN include its role in cellular biochemical functions, cardioprotection, diabetes, Alzheimer's disease, and complications associated with obesity.
β-Nicotinamide Mononucleotide (500 mg/kg; i.p.; 3 times per week for 7-10 week) prevents mtDNA damage and Dox-induced cardiac dysfunction.
Nampt KO markedly inhibits tumor progression, whereas Nampt metabolite
β-Nicotinamide Mononucleotide (300 mg/kg body weight; i.p.; once every two days for 2 weeks) significantly promotes tumor growth in C57BL/6 mice (bearing wildtype Hepa1-6 cells). The reduction and increase in NAD+ level of respective Nampt KO and β-Nicotinamide Mononucleotide-treated tumors are confirmed.
β-Nicotinamide Mononucleotide ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. β-nicotinamide mononucleotide also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian, partly through SIRT1 activation. β-Nicotinamide Mononucleotide is a product of the extracellular Nicotinamide phosphoribosyltransferase (eNAMPT) reaction and a key NAD+ intermediate.
USD
